Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa L Geddie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2017
Novel HPLC-Based Screening Method to Assess Developability of Antibody-Like MoleculesNeeraj Kohli, Melissa L Geddie
The Journal of Biological Chemistry|April 8, 2004
Rapid evolution of beta-glucuronidase specificity by saturation mutagenesis of an active site loopMelissa L Geddie, Ichiro Matsumura
Journal of Molecular Biology|May 1, 2007
Antibody-induced oligomerization and activation of an engineered reporter enzymeMelissa L Geddie, Ichiro Matsumura
Journal of Molecular Biology|September 16, 2003
A comparison of directed evolution approaches using the beta-glucuronidase model systemLori A Rowe, Melissa L Geddie, Omar B Alexander, et al.
The Journal of Biological Chemistry|August 25, 2005
Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensorsMelissa L Geddie, Taryn L O'Loughlin, Kristen K Woods, et al.
Methods in Enzymology|August 4, 2004
High throughput microplate screens for directed protein evolutionMelissa L Geddie, Lori A Rowe, Omar B Alexander, et al.
Mabs|May 12, 2015
A novel screening method to assess developability of antibody-like moleculesNeeraj Kohli, Nidhi Jain, Melissa L Geddie, et al.
Mabs|June 16, 2022
Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeuticsMelissa L Geddie, Dmitri B Kirpotin, Neeraj Kohli, et al.
Mabs|December 9, 2014
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticleKathy Zhang, Melissa L Geddie, Neeraj Kohli, et al.
Mabs|November 18, 2016
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L Geddie, Neeraj Kohli, Dmitri B Kirpotin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2017
Novel HPLC-Based Screening Method to Assess Developability of Antibody-Like MoleculesNeeraj Kohli, Melissa L Geddie
The Journal of Biological Chemistry|April 8, 2004
Rapid evolution of beta-glucuronidase specificity by saturation mutagenesis of an active site loopMelissa L Geddie, Ichiro Matsumura
Journal of Molecular Biology|May 1, 2007
Antibody-induced oligomerization and activation of an engineered reporter enzymeMelissa L Geddie, Ichiro Matsumura
Journal of Molecular Biology|September 16, 2003
A comparison of directed evolution approaches using the beta-glucuronidase model systemLori A Rowe, Melissa L Geddie, Omar B Alexander, et al.
The Journal of Biological Chemistry|August 25, 2005
Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensorsMelissa L Geddie, Taryn L O'Loughlin, Kristen K Woods, et al.
Methods in Enzymology|August 4, 2004
High throughput microplate screens for directed protein evolutionMelissa L Geddie, Lori A Rowe, Omar B Alexander, et al.
Mabs|May 12, 2015
A novel screening method to assess developability of antibody-like moleculesNeeraj Kohli, Nidhi Jain, Melissa L Geddie, et al.
Mabs|June 16, 2022
Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeuticsMelissa L Geddie, Dmitri B Kirpotin, Neeraj Kohli, et al.
Mabs|December 9, 2014
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticleKathy Zhang, Melissa L Geddie, Neeraj Kohli, et al.
Mabs|November 18, 2016
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targetingMelissa L Geddie, Neeraj Kohli, Dmitri B Kirpotin, et al.
Pageof 2